Gilead price target raised to $110 from $105 at Piper Sandler
Piper Sandler raised the firm’s price target on Gilead (GILD) to $110 from $105 and keeps an Overweight rating on the shares after the company ...
Gilead Sciences (GILD) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Feb 11, 2025, 4:30 p.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participant ...
ENDPOINTS NEWS2h
New CMO Di­et­mar Berg­er high­lights Gilead’s ‘unique sit­u­a­tion’ and its HIV am­bi­tions
CMO Dietmar Berger leads Gilead's R&D efforts with 54 clinical programs, anticipating Sunlenca's HIV PrEP launch & touting no ...
Gilead price target raised to $120 from $105 at Wells Fargo
Wells Fargo analyst Mohit Bansal raised the firm’s price target on Gilead (GILD) to $120 from $105 and keeps an Overweight rating on the ...
Gilead stock climbs 6% following Q4 report, dividend hike
Gilead (GILD) stock rose 6% post-market after the company released a Q4 earnings report that beat the Street and hiked its ...
Gilead Sciences 4Q Profit Up on HIV Product Sales, Dividend Raised
Gilead Sciences' earnings beat Wall Street expectations driven by a boost in HIV product sales. The biopharmaceutical company posted a fourth quarter profit of $1.78 billion, or $1.42 a share, ...
Gilead: Q4 Earnings Snapshot
FOSTER CITY, Calif. — FOSTER CITY, Calif. — Gilead Sciences Inc. (GILD) on Tuesday reported fourth-quarter earnings of $1.78 billion. The Foster City, California-based company said it had net income ...
Gilead outlines 2025 sales guidance with lenacapavir launch and HIV focus
Full-year sales reached $26.8 billion, driven by robust performance across HIV, oncology, and liver disease portfolios. HIV sales grew 8% year-over-year to $19.6 billion in 2024, exceeding ...
Gilead provides upbeat 2025 forecast, shares rise nearly 5%
Gilead Sciences posted fourth-quarter results that exceeded Wall Street expectations and forecast 2025 earnings above analyst ...
Gilead Soars Into Buy Zone After Obliterating Fourth-Quarter Expectations
Gilead stock popped late Tuesday after the company obliterated fourth-quarter expectations Tuesday and issued an upbeat ...